Shoulder subluxations and dislocations in non-ambulatory patients with Duchenne muscular dystrophy (DMD)

被引：0
|
作者：
Goncalves, C. [1 ]
Dos Santos, R. [1 ]
Shellenbarger, K. [1 ]
Kiefer, M. [1 ]
Shelton, E. [1 ]
Mortimer, Y. [1 ]
Gaebe, G. [1 ]
Wong, B. [1 ]
机构：
[1] UMass Mem Med Ctr, Worcester, MA USA
来源：
NEUROMUSCULAR DISORDERS | 2022年 / 32卷
关键词：
D O I：
10.1016/j.nmd.2022.07.056
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
VP.11
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [1] ESTIMATION OF HEALTH UTILITIES FOR NON-AMBULATORY DUCHENNE MUSCULAR DYSTROPHY (DMD) PATIENTS AND THEIR CAREGIVERS
    Gallop, K.
    Foerster, D.
    Lawrence, C.
    Denjean, E.
    Van Der Wild, J.
    Acaster, S.
    VALUE IN HEALTH, 2020, 23 : S602 - S602
  • [2] Benefits of initiating prednisone treatment in non-ambulatory patients with Duchenne muscular dystrophy (DMD)
    Pandya, S.
    Fox, D.
    Fox, K.
    Westfield, C.
    Su, Y.
    Campbell, K.
    Guntrum, D.
    Ciafaloni, E.
    Moxley, R. T.
    NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 825 - 825
  • [3] Associations between steroid treatment and clinical outcomes among non-ambulatory patients with Duchenne Muscular Dystrophy (DMD)
    Mayer, O.
    McDonald, C.
    Hor, K.
    Wing, J.
    Mastrandrea, N.
    Powell, A.
    Signorovitch, J.
    Marden, J.
    Freimark, J.
    Lane, H.
    Zhang, A.
    Frean, M.
    ANNALS OF NEUROLOGY, 2022, 92 : S156 - S156
  • [4] Utility of skinfold thickness measurement in non-ambulatory patients with Duchenne muscular dystrophy
    Ishizaki, Masatoshi
    Kedoin, Chika
    Ueyama, Hidetsugu
    Maeda, Yasushi
    Yamashita, Satoshi
    Ando, Yukio
    NEUROMUSCULAR DISORDERS, 2017, 27 (01) : 24 - 28
  • [5] Long term steroid use in non-ambulatory patients with Duchenne muscular dystrophy
    Eagle, M.
    MCallum, M.
    Guglieri, M.
    Straub, V.
    Bushby, K.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 772 - 772
  • [6] Usefulness of skinfold thickness measurement in non-ambulatory patients with Duchenne muscular dystrophy
    Ishizaki, M.
    Okada, M.
    Honda, Y.
    Fujimoto, A.
    Kurisaki, R.
    Maeda, Y.
    Ueyama, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 467 - 467
  • [7] Treatable renal failure found in non-ambulatory Duchenne muscular dystrophy patients
    Motoki, Takahiro
    Shimizu-Motohashi, Yuko
    Komaki, Hirofumi
    Mori-Yoshimura, Madoka
    Oya, Yasushi
    Takeshita, Eri
    Ishiyama, Akihiko
    Saito, Takashi
    Nakagawa, Eiji
    Sugai, Kenji
    Murata, Miho
    Sasaki, Masayuki
    NEUROMUSCULAR DISORDERS, 2015, 25 (10) : 754 - 757
  • [8] Eteplirsen treatment attenuates respiratory decline in ambulatory and non-ambulatory patients with Duchenne muscular dystrophy
    Khan, N.
    Han, L.
    Kinane, B.
    Gordish-Dressman, H.
    Lowes, L.
    McDonald, C.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S67 - S67
  • [9] Eteplirsen Treatment Attenuates Respiratory Decline in Ambulatory and Non-Ambulatory Patients with Duchenne Muscular Dystrophy
    Khan, Navid
    Eliopoulos, Helen
    Han, Lixin
    Kinane, T. Bernard
    Lowes, Linda P.
    Mendell, Jerry R.
    Gordish-Dressman, Heather
    Henricson, Erik K.
    McDonald, Craig M.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2019, 6 (02) : 213 - 225
  • [10] Development and evaluation of a composite time-to-progression endpoint that spans ambulatory and non-ambulatory stages of Duchenne muscular dystrophy (DMD)
    McDonald, C.
    Muntoni, F.
    Marden, J.
    Goemans, N.
    Gomez-Lievano, A.
    Zhang, A.
    Chen, Z.
    Ward, S.
    Signorovitch, J.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S82 - S82
12345